Fatal Anaphylactic Sting Reaction and Mastocytosis
Int Arch Allergy Immunol 2008;146:162-163 163 Our diagnosis was an indolent systemic mastocytosis with urticaria pigmentosa. There was no indication for specific treatment. We prescribed an emergency kit, composed of antihistamine drops, corticosteroid fluid, and an epinephrine autoinjector, and instructed the patient to carry it with her all the time and to use it in case of anaphylactic symptoms. As she had no history of anaphylactic sting reactions, no further diagnostics were done.
One year later, when she was 33, the patient was stung into the neck by a yellow jacket. At that time, she did not carry her emergency kit with her. Initially she complained about tachycardia. Within a few minutes she collapsed, lost consciousness and gasped for about 10 min. When the emergency physician arrived, her blood pressure was undetectable, and the patient was deeply comatose. She was immediately intubated, and cardiopulmonary resuscitation was started. Emergency therapy was successful and after hemodynamic stabilization the patient was transferred to an intensive care unit. Subsequently, however, she did not regain consciousness. Four days later she died of hypoxic brain damage which could be confirmed at autopsy.
VIT is a highly effective measure to prevent anaphylaxis to hymenoptera stings. In our patient there was no history of a prior anaphylactic sting reaction. Therefore, we did not perform tests to detect venom sensitization. But even if we had done so and had detected venom sensitization, we would not have recommended VIT to her. As anaphylaxis is frequent in patients with mastocytosis it is part of our clinical routine to provide these patients with an emergency kit. Our patient did not carry her emergency kit with her when she was stung. It cannot be determined whether its use would have altered the outcome. However, it is almost certain that prophylactic VIT would have saved the life of this individual patient. It is highly likely that VIT is indicated in some patients with mastocytosis even if there has been no preceding anaphylactic sting reaction. The rationale for such an individual indication can be found in the striking coincidence of mastocytosis and HVA. However, thus far, there are not yet any established criteria which would allow the identification of patients possibly eligible for such a 'prophylactic' VIT.
